Cargando…

Novel predictor of pulmonary arterial hypertension: Monocyte to HDL cholesterol ratio

Monocyte to HDL cholesterol ratio (MHR), lymphocyte to monocyte ratio (LMR), and neutrophil to lymphocyte ratio (NLR) have been proposed as novel systemic inflammatory markers. The aim of this study was to explore the association between MHR, LMR and NLR with pulmonary arterial hypertension (PAH). T...

Descripción completa

Detalles Bibliográficos
Autores principales: Bilik, Mehmet Zihni, Oylumlu, Muhammed, Oylumlu, Mustafa, Acun, Baris, Arik, Baran, Arslan, Bayram, Acet, Halit, Polat, Nihat, Akil, Mehmet Ata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410685/
https://www.ncbi.nlm.nih.gov/pubmed/36042653
http://dx.doi.org/10.1097/MD.0000000000029973
_version_ 1784775152339255296
author Bilik, Mehmet Zihni
Oylumlu, Muhammed
Oylumlu, Mustafa
Acun, Baris
Arik, Baran
Arslan, Bayram
Acet, Halit
Polat, Nihat
Akil, Mehmet Ata
author_facet Bilik, Mehmet Zihni
Oylumlu, Muhammed
Oylumlu, Mustafa
Acun, Baris
Arik, Baran
Arslan, Bayram
Acet, Halit
Polat, Nihat
Akil, Mehmet Ata
author_sort Bilik, Mehmet Zihni
collection PubMed
description Monocyte to HDL cholesterol ratio (MHR), lymphocyte to monocyte ratio (LMR), and neutrophil to lymphocyte ratio (NLR) have been proposed as novel systemic inflammatory markers. The aim of this study was to explore the association between MHR, LMR and NLR with pulmonary arterial hypertension (PAH). The study is a single-center, retrospective Cross-sectional study. The study group consisted of 73 patients with PAH and the control group 77 participants without cardiac pathology as determined by echocardiography. On admission, blood sampling to calculate MHR, LMR, NLR, and detailed clinical data were obtained. According to the Pearson test, systolic pulmonary artery pressure (PAP) value Higher MHR, NLR and lower LMR that indicates an enhanced inflammation were significantly increased in patients with PAH when compared with controls. Compared to many other inflammatory markers, these markers are widely available. positively correlated with the MHR and NLR (r:.35, P < .001 and r:.33, P < .001, respectively), but negatively correlated with LMR (r: −.26, P = .001). After multivariate logistic regression analysis, MHR, LMR, and NLR remained as significant predictors of PAH (OR: 2.651, 95% CI: 1.227–5.755, P = .007; OR: 0.647, 95% CI:0.450–0.931, P = .005; OR: 1.350, 95% CI: 1.054–1.650 P = .030, respectively).
format Online
Article
Text
id pubmed-9410685
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94106852022-08-26 Novel predictor of pulmonary arterial hypertension: Monocyte to HDL cholesterol ratio Bilik, Mehmet Zihni Oylumlu, Muhammed Oylumlu, Mustafa Acun, Baris Arik, Baran Arslan, Bayram Acet, Halit Polat, Nihat Akil, Mehmet Ata Medicine (Baltimore) Research Article Monocyte to HDL cholesterol ratio (MHR), lymphocyte to monocyte ratio (LMR), and neutrophil to lymphocyte ratio (NLR) have been proposed as novel systemic inflammatory markers. The aim of this study was to explore the association between MHR, LMR and NLR with pulmonary arterial hypertension (PAH). The study is a single-center, retrospective Cross-sectional study. The study group consisted of 73 patients with PAH and the control group 77 participants without cardiac pathology as determined by echocardiography. On admission, blood sampling to calculate MHR, LMR, NLR, and detailed clinical data were obtained. According to the Pearson test, systolic pulmonary artery pressure (PAP) value Higher MHR, NLR and lower LMR that indicates an enhanced inflammation were significantly increased in patients with PAH when compared with controls. Compared to many other inflammatory markers, these markers are widely available. positively correlated with the MHR and NLR (r:.35, P < .001 and r:.33, P < .001, respectively), but negatively correlated with LMR (r: −.26, P = .001). After multivariate logistic regression analysis, MHR, LMR, and NLR remained as significant predictors of PAH (OR: 2.651, 95% CI: 1.227–5.755, P = .007; OR: 0.647, 95% CI:0.450–0.931, P = .005; OR: 1.350, 95% CI: 1.054–1.650 P = .030, respectively). Lippincott Williams & Wilkins 2022-08-26 /pmc/articles/PMC9410685/ /pubmed/36042653 http://dx.doi.org/10.1097/MD.0000000000029973 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle Research Article
Bilik, Mehmet Zihni
Oylumlu, Muhammed
Oylumlu, Mustafa
Acun, Baris
Arik, Baran
Arslan, Bayram
Acet, Halit
Polat, Nihat
Akil, Mehmet Ata
Novel predictor of pulmonary arterial hypertension: Monocyte to HDL cholesterol ratio
title Novel predictor of pulmonary arterial hypertension: Monocyte to HDL cholesterol ratio
title_full Novel predictor of pulmonary arterial hypertension: Monocyte to HDL cholesterol ratio
title_fullStr Novel predictor of pulmonary arterial hypertension: Monocyte to HDL cholesterol ratio
title_full_unstemmed Novel predictor of pulmonary arterial hypertension: Monocyte to HDL cholesterol ratio
title_short Novel predictor of pulmonary arterial hypertension: Monocyte to HDL cholesterol ratio
title_sort novel predictor of pulmonary arterial hypertension: monocyte to hdl cholesterol ratio
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410685/
https://www.ncbi.nlm.nih.gov/pubmed/36042653
http://dx.doi.org/10.1097/MD.0000000000029973
work_keys_str_mv AT bilikmehmetzihni novelpredictorofpulmonaryarterialhypertensionmonocytetohdlcholesterolratio
AT oylumlumuhammed novelpredictorofpulmonaryarterialhypertensionmonocytetohdlcholesterolratio
AT oylumlumustafa novelpredictorofpulmonaryarterialhypertensionmonocytetohdlcholesterolratio
AT acunbaris novelpredictorofpulmonaryarterialhypertensionmonocytetohdlcholesterolratio
AT arikbaran novelpredictorofpulmonaryarterialhypertensionmonocytetohdlcholesterolratio
AT arslanbayram novelpredictorofpulmonaryarterialhypertensionmonocytetohdlcholesterolratio
AT acethalit novelpredictorofpulmonaryarterialhypertensionmonocytetohdlcholesterolratio
AT polatnihat novelpredictorofpulmonaryarterialhypertensionmonocytetohdlcholesterolratio
AT akilmehmetata novelpredictorofpulmonaryarterialhypertensionmonocytetohdlcholesterolratio